Care Global Pharmacy

Olumiant (Baricitinib) 4 mg is a medication used to treat specific medical conditions by targeting the immune system. It belongs to a class of drugs called Janus kinase (JAK) inhibitors, which modulate the activity of the immune system to reduce inflammation and disease progression.

1. Rheumatoid Arthritis (RA):

   • Used for the treatment of moderate to severe rheumatoid arthritis in adults.
   • Typically prescribed for patients who have had an inadequate response or intolerance to one or more disease-modifying antirheumatic drugs (DMARDs).
   • Helps reduce joint pain, swelling, and stiffness and slows the progression of joint damage.

2. Alopecia Areata:

   • Approved for treating severe alopecia areata, an autoimmune disorder that causes hair loss.

3. Atopic Dermatitis (Eczema):

   • Used for moderate to severe cases in adults where topical treatments or other therapies are insufficient.

4. COVID-19-Related Hospitalization:

   • Used in some countries for hospitalized adults with COVID-19 requiring oxygen or ventilatory support, as part of anti-inflammatory therapy in severe cases.

5. Systemic Lupus Erythematosus (SLE):

   • In certain regions, it may be explored or used off-label for autoimmune conditions like lupus when other treatments are inadequate.

• Typically 4 mg once daily, but the dosage may be adjusted based on the condition, response to treatment, or patient-specific factors such as kidney function.

• Common: Nausea, upper respiratory infections, headache.
• Serious (rare): Risk of blood clots, serious infections, liver enzyme elevation, and low blood counts.

• Should not be used in patients with active infections.
• Avoid use in pregnant or breastfeeding women unless specifically recommended by a doctor.
• Regular monitoring of blood counts, liver function, and kidney function is recommended during treatment.

Consult your doctor for personalized advice before starting Olumiant to ensure it is appropriate for your medical condition.

0.5mg Dostiheal (Cabergoline) Tablet is a medication primarily used to treat conditions related to prolactin imbalances. Cabergoline works by acting on dopamine receptors in the brain, reducing the secretion of prolactin, a hormone produced by the pituitary gland. The main uses of Dostiheal (Cabergoline) include:

• Treatment of High Prolactin Levels: Cabergoline is most commonly used to treat hyperprolactinemia, a condition where there is an excess of prolactin in the blood. High prolactin levels can lead to issues such as irregular menstrual cycles, infertility, and galactorrhea (inappropriate milk production). Cabergoline helps lower prolactin levels, restoring normal hormonal balance.
• Prolactin-Secreting Tumors (Prolactinomas): It is also used to treat prolactinomas, benign tumors of the pituitary gland that secrete excess prolactin. Cabergoline can reduce the size of the tumor and normalize prolactin levels, improving symptoms like menstrual irregularities and infertility.

• Restoring Ovulation: In women with ovulatory infertility caused by high prolactin levels, Cabergoline can help restore regular ovulation, improving the chances of pregnancy. This is especially useful in conditions like polycystic ovary syndrome (PCOS) and hyperprolactinemic infertility.

• Dopamine Agonist: Cabergoline can sometimes be used off-label to treat Parkinson’s disease, a condition where the brain lacks adequate dopamine. Although more commonly used drugs for Parkinson's include levodopa, cabergoline is a dopamine agonist that stimulates dopamine receptors, helping alleviate symptoms like tremors and rigidity.

• Treatment of Acromegaly: Cabergoline is also used in the treatment of acromegaly, a condition caused by excess growth hormone, typically due to a pituitary tumor. While somatostatin analogs are the mainstay of treatment, cabergoline may be used as an additional or alternative treatment to lower growth hormone levels.

Tofajak 5mg is a brand name for Tofacitinib, a Janus kinase (JAK) inhibitor used to treat several autoimmune and inflammatory conditions. Here are the main uses and benefits of Tofajak 5mg (Tofacitinib) tablets:

• Tofacitinib is commonly used to treat rheumatoid arthritis (RA), a condition in which the immune system attacks the joints, leading to pain, swelling, and joint damage. Tofacitinib helps reduce inflammation, pain, and prevents further joint damage by inhibiting the activity of certain enzymes (JAKs) involved in the inflammatory process.
• Tofacitinib is used in moderate to severe cases of RA, especially in patients who do not respond well to traditional disease-modifying antirheumatic drugs (DMARDs) or biological agents like tumor necrosis factor (TNF) inhibitors.

• Tofacitinib is also approved for the treatment of psoriatic arthritis, a form of arthritis that occurs in people with psoriasis, an autoimmune skin disease. It helps manage both the joint inflammation and skin symptoms by reducing inflammation in the body.

• Tofacitinib is used to treat moderate to severe ulcerative colitis, a type of inflammatory bowel disease (IBD) that causes chronic inflammation and ulcers in the colon. Tofacitinib works by suppressing the overactive immune response that leads to inflammation in the intestines, reducing symptoms such as diarrhea, abdominal pain, and rectal bleeding.

• Although not approved for all autoimmune diseases, Tofacitinib may be used off-label in some cases to treat other conditions where the immune system attacks the body, such as vitiligo or alopecia areata, based on the physician's discretion.

2.5mg Fempro (Letrozole) Tablets are used primarily in the treatment of breast cancer, particularly in postmenopausal women, as well as for other hormonal conditions. Letrozole is an aromatase inhibitor that works by lowering the levels of estrogen in the body, which can help prevent the growth of estrogen-dependent cancers. The main uses of Fempro (Letrozole) include:

• Early-Stage Estrogen Receptor-Positive (ER+) Breast Cancer: Letrozole is most commonly used as an adjuvant therapy for early-stage breast cancer in postmenopausal women. It helps reduce the risk of recurrence by inhibiting the aromatase enzyme, which is responsible for producing estrogen. By lowering estrogen levels, the drug helps slow or stop the growth of estrogen-dependent breast cancer cells.
• Metastatic Breast Cancer: Letrozole is also used in the treatment of metastatic estrogen receptor-positive breast cancer in postmenopausal women. It is particularly useful for cancers that have spread to other parts of the body, as it helps control the growth of these tumors by lowering estrogen levels.
• Neoadjuvant Therapy (Preoperative Treatment): In some cases, Letrozole is used as a neoadjuvant therapy, meaning it is given before surgery to shrink the tumor, making it easier to remove.

• High-Risk Prevention: Letrozole may be prescribed off-label to prevent breast cancer in postmenopausal women at high risk of developing the disease, such as those with a family history of breast cancer or certain genetic mutations (e.g., BRCA1 or BRCA2). It may help reduce the likelihood of developing estrogen-dependent breast cancer in high-risk individuals.

• Ovulation Induction in Infertility: Letrozole is sometimes used off-label to treat infertility in women, particularly those with polycystic ovary syndrome (PCOS). Letrozole can stimulate ovulation by lowering estrogen levels, which can help induce ovulation and increase the chances of conception. It is considered an alternative to clomiphene citrate for this purpose.

• Treatment of Ovarian Cancer: Letrozole has been investigated for use in the treatment of ovarian cancer, particularly in cases where the cancer is hormone receptor-positive. It may be used to help lower estrogen levels, which could slow the growth of estrogen-dependent ovarian tumors.

Femistra (with the active ingredient Anastrozole) is a medication used primarily in the treatment of breast cancer in postmenopausal women. The 1mg Femistra Anastrozole Tablet is commonly prescribed for the following uses:

• Anastrozole is most commonly used to treat hormone receptor-positive (estrogen receptor-positive or ER-positive) breast cancer in postmenopausal women. In these cases, the cancer cells grow in response to estrogen.
• Anastrozole works by inhibiting the enzyme aromatase, which is responsible for the production of estrogen in the body. By lowering estrogen levels, it slows or stops the growth of hormone-dependent breast cancer cells.

• Femistra is often used as adjuvant therapy following surgery (such as mastectomy or lumpectomy) in women who have early-stage hormone receptor-positive breast cancer. The goal is to reduce the risk of recurrence by lowering estrogen levels after the removal of the tumor.
• It is typically prescribed after chemotherapy or radiation therapy to help prevent the return of cancer.

• Anastrozole can also be used in the treatment of advanced or metastatic breast cancer in postmenopausal women. It can help to slow the progression of the disease when the cancer has spread to other parts of the body.

• In some cases, Femistra is used to reduce the risk of breast cancer recurrence in women who have already been treated for early-stage breast cancer and are at high risk of the cancer returning. The medication is especially effective in postmenopausal women, where it can be a key part of long-term cancer management.

Anastrozole is an aromatase inhibitor. It works by inhibiting aromatase, an enzyme that converts androgens (hormones produced by the adrenal glands) into estrogens. In postmenopausal women, the ovaries no longer produce estrogen, and most of the estrogen is produced in other tissues through aromatization. By blocking this enzyme, Femistra lowers estrogen levels in the body, which helps prevent the growth of estrogen-dependent breast cancer cells.

• The usual dose of Femistra is 1mg taken orally once a day, with or without food.
• It is typically prescribed for a 5-year period for the treatment of hormone receptor-positive breast cancer, although the duration may vary based on individual treatment plans and response.

Common side effects of Femistra may include:

• Hot flashes or flushing
• Joint pain or stiffness
• Fatigue
• Nausea or vomiting
• Bone thinning (osteoporosis) or fractures, due to the reduction in estrogen
• Headaches
• Mood changes or depression

In rare cases, more serious side effects can occur, such as blood clots or heart problems.

Fenbendazole, marketed under brand names like Wormental, is a broad-spectrum anthelmintic (anti-worm) medication primarily used in animals to treat various types of parasitic infections, including roundworms, hookworms, tapeworms, and whipworms. It works by disrupting the worms' cellular structure, leading to their elimination.

Regarding human use, fenbendazole is not officially approved by regulatory bodies such as the FDA for treating humans. However, there have been anecdotal reports and some alternative medicine proponents suggesting its use for various purposes, including parasitic infections and even cancer treatment, although there is no substantial clinical evidence to support these claims for humans. Some studies on fenbendazole's effects have been conducted in animals, but it is not widely recommended or prescribed for human use outside of veterinary contexts.

If you are considering taking fenbendazole for any reason, it is important to consult with a healthcare provider first to understand the potential risks and benefits, as well as ensure that the dosage is safe for human use.

Jardiance (empagliflozin) is a medication primarily used to treat type 2 diabetes, but it can also be prescribed for other purposes, such as heart failure and chronic kidney disease. Specifically, a 12.5 mg dose of Jardiance typically has the following uses:

1. Type 2 Diabetes: Jardiance helps lower blood sugar levels by preventing the kidneys from reabsorbing glucose back into the blood. It promotes glucose excretion in urine, which helps control blood sugar.

2. Heart Failure: Jardiance is used to reduce the risk of hospitalization and death in patients with heart failure with reduced ejection fraction (HFrEF), regardless of whether they have diabetes.

3. Chronic Kidney Disease (CKD): Jardiance can be prescribed to reduce the progression of kidney disease and the risk of kidney failure in people with diabetes and chronic kidney disease.

It’s important to take Jardiance as prescribed by your healthcare provider and regularly monitor kidney function, as the medication can impact kidney health.

20mg Tamox (Tamoxifen Citrate) Tablets are commonly used in the treatment and prevention of certain types of cancer, particularly breast cancer. The main uses of Tamoxifen include:

1. Breast Cancer Treatment:

   • Early-Stage Breast Cancer: Tamoxifen is widely used as an adjuvant therapy for early-stage estrogen receptor-positive (ER-positive) breast cancer. It helps reduce the risk of recurrence by blocking estrogen's effects on the cancer cells.
   • Metastatic Breast Cancer: Tamoxifen is used in the treatment of advanced or metastatic ER-positive breast cancer, where cancer has spread to other parts of the body. It helps slow the progression of the disease.

2. Breast Cancer Prevention:

   • High-Risk Prevention: Tamoxifen is also used in women at high risk for developing breast cancer (due to family history or genetic factors) to reduce the risk of developing the disease. This use is especially beneficial for postmenopausal women, though it can also be used in premenopausal women.
   • Prophylaxis in High-Risk Populations: Women with a high risk of breast cancer, such as those with BRCA1 or BRCA2 mutations, may be prescribed Tamoxifen as a preventive measure to reduce their likelihood of developing breast cancer.

3. Infertility Treatment (Off-Label Use):

   • Ovulation Induction: Tamoxifen is sometimes used off-label to treat infertility in women, particularly for those with ovulation disorders like polycystic ovary syndrome (PCOS). It works by stimulating ovulation and increasing the chances of conception.

4. Male Breast Cancer: In rare cases, Tamoxifen may be used to treat breast cancer in men, especially those with estrogen receptor-positive tumors.

5. Endometrial Cancer (Off-Label Use):

   • While not a primary treatment, Tamoxifen is occasionally used off-label in the treatment of endometrial cancer, especially in cases where estrogen therapy might stimulate cancer growth.

• Hormone Blocker: Tamoxifen works as a selective estrogen receptor modulator (SERM), which means it blocks the estrogen hormone from binding to cancer cells. This helps to slow or stop the growth of estrogen-dependent cancers, such as most breast cancers.

• Side Effects: Common side effects of Tamoxifen may include hot flashes, vaginal dryness, nausea, weight gain, mood swings, and fatigue. It may also increase the risk of more serious side effects such as blood clots, stroke, and endometrial cancer (in rare cases).

• Bone Health: Tamoxifen can have protective effects on bone density, which may be beneficial for women at risk of osteoporosis after menopause. However, it can also have adverse effects on bone health in some cases, especially if used long-term.

• Monitoring: Patients using Tamoxifen are often monitored regularly for potential side effects, such as changes in blood count, liver function, and signs of blood clots or endometrial cancer.

Product Description:

F-Pecia Tablet (Finasteride 1mg) is primarily used for the treatment of male pattern baldness, also known as androgenetic alopecia. It works by inhibiting the production of dihydrotestosterone (DHT), the hormone responsible for hair loss in men. By reducing DHT levels in the scalp, F-Pecia helps to slow down hair loss and promote hair regrowth in men with mild to moderate baldness.

Consistent use of F-Pecia as prescribed can lead to visible improvement in hair growth over several months, though results may vary among individuals. This medication is not suitable for use by women or children. The 1mg dosage of Finasteride is specifically designed to combat hair loss, as opposed to the 5mg dosage, which is used for the treatment of prostate issues

Udiliv (Ursodeoxycholic Acid, 300 mg) is a medication primarily used to treat liver-related conditions. It is a naturally occurring bile acid that helps to improve liver function and reduce the amount of toxic bile acids in the liver. Some of the common uses of Udiliv include:

1. Gallstones: Udiliv is used to dissolve cholesterol gallstones in patients who are not candidates for surgery, or to prevent the formation of gallstones in patients who have had their gallbladder removed.

2. Primary Biliary Cirrhosis (PBC): This is a chronic liver disease where the bile ducts become damaged and inflamed. Udiliv can help slow the progression of this disease by improving bile flow and reducing liver damage.

3. Non-alcoholic Fatty Liver Disease (NAFLD): Some evidence suggests that Udiliv may help reduce liver inflammation and improve liver function in people with NAFLD.

4. Liver Disorders Related to Cystic Fibrosis: In individuals with cystic fibrosis, Udiliv can help reduce liver damage caused by bile acid buildup.

5. Cholestasis: In cases where bile flow is reduced or blocked (such as in pregnancy-related cholestasis), Udiliv can be used to improve bile flow and reduce symptoms.

As always, it's essential to follow your healthcare provider's instructions on dosage and usage, as this medication is typically prescribed for specific conditions and should be used under medical supervision.

Fibristal (brand name for Ulipristal Acetate) is a medication primarily used for managing uterine fibroids and related symptoms. The 5mg dosage of Ulipristal Acetate tablets is commonly prescribed for the following uses:

• Ulipristal Acetate is mainly used for the treatment of moderate to severe symptoms of uterine fibroids in women who are not yet in menopause. Fibroids are non-cancerous growths in the uterus that can cause symptoms like heavy menstrual bleeding, pelvic pain, and pressure on surrounding organs. Ulipristal acetate helps to shrink fibroids and reduce the severity of associated symptoms.

• It works by modulating progesterone receptors in the uterus, which can reduce fibroid size and help control symptoms such as heavy bleeding and pain. It is often used as a short-term treatment to manage fibroid symptoms before surgery or as an alternative to surgery for women who prefer to avoid invasive procedures.

• Ulipristal acetate can be used as a pre-surgical treatment to shrink fibroids before a myomectomy (surgical removal of fibroids) or hysterectomy (removal of the uterus). By shrinking the fibroids, it can make the surgery easier and less risky, and may reduce the need for blood transfusions during the procedure.

Ulipristal acetate is a progesterone receptor modulator that works by interfering with the effects of progesterone on the uterus. By blocking or modifying the action of progesterone, it can reduce the size of fibroids and alleviate symptoms like bleeding and pain.

Common side effects of Ulipristal Acetate (Fibristal) include:

• Headache
• Hot flashes
• Abdominal pain
• Nausea
• Breast tenderness
• Mood swings

Less common side effects may include changes in liver function, and in rare cases, the development of ovarian cysts. Regular monitoring of liver function is recommended during treatment.

Aricep (Donepezil HCl) 10 mg is a medication used primarily to treat symptoms of Alzheimer's disease, a progressive neurological condition that leads to memory loss, confusion, and changes in behavior. Donepezil is an acetylcholinesterase inhibitor, which works by increasing the levels of acetylcholine in the brain, a neurotransmitter involved in memory and learning.

• Mild to moderate Alzheimer's disease: Donepezil is used to improve or stabilize cognitive function, memory, and behavior.
• Severe Alzheimer’s disease: In some cases, donepezil may also be prescribed for more advanced stages of Alzheimer's to slow the progression of symptoms.

• Donepezil is sometimes used off-label for vascular dementia, which is caused by reduced blood flow to the brain due to conditions like stroke or high blood pressure.

• Acetylcholine Regulation: Donepezil inhibits the enzyme acetylcholinesterase, which breaks down acetylcholine. By inhibiting this enzyme, more acetylcholine is available in the brain, which helps improve communication between nerve cells and supports cognitive functions like memory and attention.

• Starting Dose: Typically, treatment begins with a 5 mg daily dose, usually taken at bedtime to reduce side effects like nausea.
• Maintenance Dose: The dose is gradually increased to 10 mg daily after 4 to 6 weeks if the patient tolerates it well. In some cases, a dose of 23 mg daily may be considered for further progression.
• Administration: Taken once daily at the same time each day, preferably in the evening, with or without food.

• Gastrointestinal Issues: Nausea, diarrhea, loss of appetite
• Insomnia or vivid dreams
• Muscle cramps
• Fatigue or dizziness
• Headaches

• Bradycardia (slow heart rate)
• Heart block or fainting
• Severe gastrointestinal issues (vomiting or GI bleeding)
• Severe allergic reactions (rash, itching, swelling)

1. Cardiac Conditions:

   • Use with caution in patients with heart problems, especially those with bradycardia, as donepezil can slow the heart rate.

2. Gastrointestinal Disorders:

   • Caution in individuals with a history of gastric ulcers or GI bleeding, as donepezil may increase the risk of stomach issues.

3. Liver Impairment:

   • Dosage adjustments may be necessary for patients with liver dysfunction, as donepezil is metabolized in the liver.

4. Seizure History:

   • Caution is advised for individuals with a history of seizures.

5. Pregnancy and Breastfeeding:

   • Donepezil should only be used in pregnancy if absolutely necessary. It is not known whether donepezil passes into breast milk, so use during breastfeeding is not recommended unless deemed essential by a doctor.

• Anticholinergic medications (e.g., antihistamines, tricyclic antidepressants) may reduce the effectiveness of donepezil.
• Medications affecting heart rate (e.g., beta-blockers or calcium channel blockers) should be used cautiously due to the potential for bradycardia.
• Nonsteroidal anti-inflammatory drugs (NSAIDs): There may be an increased risk of gastrointestinal bleeding when combined with donepezil.

1000mg Amoxyheal CV Amoxicillin Tablet is a combination medication that contains Amoxicillin (an antibiotic) and Clavulanic Acid. It is primarily used to treat a wide range of bacterial infections. The main uses of Amoxyheal CV 1000mg Tablet include:

1. Bacterial Infections: The combination of Amoxicillin and Clavulanic Acid is effective in treating infections caused by susceptible bacteria. Amoxicillin is a penicillin-type antibiotic that works by inhibiting the growth of bacteria, while Clavulanic Acid helps prevent the bacteria from developing resistance to amoxicillin, making it effective against a broader range of bacterial infections.

2. Respiratory Tract Infections: It is commonly used to treat respiratory infections, including pneumonia, bronchitis, sinusitis, and tonsillitis, where bacteria are the cause.

3. Urinary Tract Infections (UTIs): Amoxyheal CV is effective in treating urinary tract infections, including cystitis and pyelonephritis.

4. Skin and Soft Tissue Infections: The tablet is often prescribed for bacterial infections of the skin and soft tissues, such as cellulitis, abscesses, or wound infections.

5. Ear and Throat Infections: It is used for treating otitis media (middle ear infections) and pharyngitis or tonsillitis caused by bacteria.

6. Dental Infections: Amoxyheal CV may be used to treat infections following dental procedures or in cases of periodontal abscesses or tooth infections.

7. Sinus Infections (Sinusitis): The combination antibiotic is effective for treating sinus infections caused by bacteria.

8. Infections in Immunocompromised Individuals: It may be prescribed for infections in patients with weakened immune systems, where bacteria are harder to treat with regular antibiotics alone.

• Dosage and Duration: Always follow the prescribed dosage and complete the full course of treatment to prevent antibiotic resistance and ensure the infection is fully treated.
• Allergic Reactions: If you are allergic to penicillin or have had previous allergic reactions to antibiotics, inform your healthcare provider.
• Consult a Healthcare Provider: Always consult a doctor before starting this medication, especially if you have any pre-existing health conditions, such as liver disease, kidney problems, or gastrointestinal disorders.

It is crucial to use Amoxyheal CV under the supervision of a healthcare professional to ensure its safe and effective use.

Kryxana (Ribociclib) 200 mg is a targeted cancer therapy used in the treatment of certain types of breast cancer. It belongs to a class of drugs called cyclin-dependent kinase (CDK) 4/6 inhibitors.

• Indicated for the treatment of postmenopausal women or pre/perimenopausal women with:
  • Advanced or metastatic breast cancer that is hormone receptor-positive (HR+) and human epidermal growth factor receptor 2-negative (HER2-).
• Used in combination with:
  • Aromatase inhibitors (e.g., letrozole) as initial endocrine-based therapy.
  • Fulvestrant, especially in cases where cancer has progressed after prior endocrine therapy.

• Ribociclib selectively inhibits CDK4 and CDK6, proteins involved in the regulation of cell cycle progression.
• By blocking these proteins, it prevents cancer cells from multiplying and slows tumor growth.

• Standard Dosage:

  • 600 mg once daily (3 tablets of 200 mg) for 21 consecutive days followed by 7 days off (28-day cycle).
  • Taken in combination with another hormonal therapy (e.g., letrozole or fulvestrant).
  • Should be taken at the same time each day, with or without food.

• Adjustments: Dose may be reduced based on side effects, typically to 400 mg or 200 mg daily.

• Nausea and vomiting
• Fatigue
• Diarrhea or constipation
• Hair thinning or loss
• Loss of appetite
• Mouth sores (stomatitis)
• Low blood cell counts (e.g., neutropenia)

• QT Prolongation: Risk of abnormal heart rhythm; regular ECG monitoring is required.
• Hepatotoxicity: Elevated liver enzymes (ALT/AST); periodic liver function tests are necessary.
• Severe Neutropenia: Increased risk of infections due to low white blood cell counts.
• Interstitial Lung Disease/Pneumonitis: Rare but serious.

1. Heart Health:

   • Regular monitoring of heart function is necessary, especially in patients with a history of heart disease.

2. Liver Function:

   • Dose adjustments may be required in patients with impaired liver function.

3. Drug Interactions:

   • Avoid strong CYP3A4 inhibitors (e.g., ketoconazole) and inducers (e.g., rifampin) as they may alter ribociclib levels.
   • Grapefruit and grapefruit juice should be avoided.

4. Pregnancy and Breastfeeding:

   • Contraindicated during pregnancy due to the risk of fetal harm.
   • Not recommended while breastfeeding.

5. Contraception:

   • Effective contraception is required during treatment and for at least 3 weeks after discontinuation.

• Regular blood tests to monitor:
  • Blood counts (to detect neutropenia)
  • Liver enzymes (to check for hepatotoxicity)
  • Electrocardiograms (ECG) (to monitor heart rhythm)

• Ribociclib has been shown to significantly extend progression-free survival (PFS) in patients with HR+, HER2- advanced breast cancer when used in combination with hormonal therapies.

Always take Kryxana (Ribociclib) under the supervision of a healthcare provider experienced in cancer treatment.

50mg Thyrox (Thyroxine Sodium) Tablets are synthetic forms of the thyroid hormone levothyroxine, used primarily to treat thyroid-related conditions, particularly hypothyroidism (an underactive thyroid).

1. Hypothyroidism (Underactive Thyroid)

   • Treats hypothyroidism by supplementing the body with thyroid hormone. This condition occurs when the thyroid gland does not produce enough thyroid hormones (T3 and T4), leading to symptoms such as fatigue, weight gain, cold intolerance, dry skin, and constipation. Thyroxine helps restore normal metabolism and energy levels.

2. Thyroid Cancer

   • After the removal of the thyroid gland (e.g., due to cancer), levothyroxine is given to replace the hormones and suppress the growth of any remaining thyroid tissue or cancerous cells.

3. Goiter (Enlarged Thyroid)

   • Treats goiter, which is often caused by iodine deficiency or autoimmune conditions like Hashimoto's thyroiditis. Thyroxine reduces the size of the goiter by normalizing thyroid hormone levels.

4. Thyroid Hormone Replacement Therapy

   • Used as a lifelong hormone replacement in cases where the thyroid is not functioning properly or has been removed.

Veltam Plus is a combination tablet containing Tamsulosin and Dutasteride, used primarily for the treatment of benign prostatic hyperplasia (BPH), also known as enlarged prostate. Here's how each component works and the primary uses:

• Veltam Plus is most commonly prescribed to manage BPH, a condition where the prostate gland enlarges, causing urinary problems such as difficulty in starting urination, frequent urination, weak urine stream, and incomplete emptying of the bladder.
• Tamsulosin works by relaxing the muscles in the prostate and bladder neck, making it easier to urinate and relieving symptoms like urgency and weak stream.
• Dutasteride reduces the size of the prostate by inhibiting the enzyme 5-alpha-reductase, which converts testosterone to dihydrotestosterone (DHT), a hormone responsible for prostate growth. This helps improve urinary flow over time.

• The combination of Tamsulosin and Dutasteride effectively improves urinary symptoms in men with BPH. While Tamsulosin helps provide immediate relief by relaxing muscles, Dutasteride works gradually to shrink the prostate, offering long-term symptom improvement.

• Veltam Plus can help prevent acute urinary retention, a condition where the bladder becomes unable to empty, which can occur due to BPH. This can reduce the need for catheterization or surgical intervention.

• By reducing prostate size and improving symptoms, Veltam Plus can delay or even prevent the need for surgical procedures like transurethral resection of the prostate (TURP), which is often required in severe cases of BPH.

• Dutasteride helps to shrink the prostate over time, offering a long-term solution for BPH management and potentially reducing the risk of further complications associated with an enlarged prostate.

• By reducing the symptoms of BPH, Veltam Plus improves the overall quality of life for individuals suffering from urinary issues related to prostate enlargement.

Tadalista (20mg Tadalafil) is a medication commonly used to treat conditions related to erectile dysfunction (ED) and benign prostatic hyperplasia (BPH). Its main uses include:

1. Erectile Dysfunction (ED): Tadalafil is used to treat ED, a condition where a man is unable to achieve or maintain an erection sufficient for sexual intercourse. Tadalista works by increasing blood flow to the penis when sexually aroused, helping to achieve and sustain an erection.

2. Benign Prostatic Hyperplasia (BPH): Tadalafil is also used to treat symptoms of BPH, a condition in which the prostate gland becomes enlarged, causing urinary problems such as frequent urination, difficulty starting urination, or weak urine flow. Tadalafil helps to relax the muscles of the prostate and bladder, improving urinary flow.

3. Pulmonary Arterial Hypertension (PAH): Although not as commonly prescribed for this purpose, tadalafil is sometimes used to treat pulmonary arterial hypertension, a condition where the blood pressure in the lungs is abnormally high. It helps by relaxing the blood vessels in the lungs, allowing blood to flow more easily.

12 mg Ivermectin Tablets are an anthelmintic (anti-parasitic) medication used to treat a variety of parasitic infections in both humans and animals. It works by disrupting the nerve and muscle function of parasites, leading to their paralysis and death.

1. Onchocerciasis (River Blindness):

   • Ivermectin is most commonly used to treat onchocerciasis, also known as river blindness, caused by the parasitic worm Onchocerca volvulus. It helps to kill the microfilariae (larvae) of the worm, thereby reducing the symptoms and preventing the progression of the disease, such as blindness and skin issues.

2. Strongyloidiasis (Threadworm Infection):

   • It is effective in treating strongyloidiasis, an infection caused by the threadworm Strongyloides stercoralis. The drug kills the larvae and adult worms, helping to alleviate symptoms such as abdominal pain, diarrhea, and itching.

3. Scabies:

   • Ivermectin can be used to treat scabies, a highly contagious skin condition caused by the Sarcoptes scabiei mite. It works by killing the mites and their eggs. Ivermectin is usually prescribed for patients who do not respond well to topical treatments like permethrin.

4. Lice:

   • Ivermectin can be used to treat lice infestations, such as head lice or pubic lice. It kills the lice and their eggs, offering an effective alternative to topical treatments.

5. Filariasis:

   • It is used to treat filariasis, a parasitic infection caused by filarial worms, particularly Wuchereria bancrofti and Brugia malayi, which can cause swelling of the limbs (elephantiasis). Ivermectin helps by killing the microfilariae in the bloodstream, reducing the transmission of the disease.

Dyronib Tablets (Dasatinib) is a targeted therapy medication that belongs to the class of tyrosine kinase inhibitors (TKIs). It is used in the treatment of specific types of cancers affecting the blood and bone marrow.

• Effective in treating Philadelphia chromosome-positive (Ph+) CML across all phases:
  • Chronic phase.
  • Accelerated phase.
  • Blast phase.
• Often used as first-line therapy or in cases where other TKIs, like imatinib, have failed.

• Used for Philadelphia chromosome-positive (Ph+) ALL in adults.
• Typically part of combination therapy with chemotherapy or corticosteroids.

• Administered to patients who have developed resistance to or cannot tolerate first-line TKIs, such as imatinib.

Dasatinib inhibits multiple tyrosine kinases, including BCR-ABL, a protein that drives the growth of Ph+ leukemic cells. By blocking BCR-ABL and related pathways, Dasatinib prevents the proliferation of abnormal cancer cells.

• Typical Dose for CML: 100 mg once daily.
• For Ph+ ALL or Advanced CML Phases: 140 mg daily (dose may vary based on response and tolerance).
• Tablets should be swallowed whole, with or without food.

Dyronib Tablets (Dasatinib) 20 mg is a tyrosine kinase inhibitor (TKI) used primarily in the treatment of certain types of leukemia and chronic myelogenous leukemia (CML). It works by blocking the signals that help cancer cells grow and divide, specifically targeting the BCR-ABL fusion protein, which is responsible for the uncontrolled growth of leukemia cells.

• Philadelphia Chromosome-Positive CML:
  Dyronib is used for the treatment of Ph+ CML in adults and children, particularly for patients who are newly diagnosed or for those whose disease has become resistant to or intolerant of other treatments such as imatinib.
  • It is used across all phases of CML (chronic, accelerated, and blast phase).

• Philadelphia Chromosome-Positive ALL:
  Dyronib is also used to treat Ph+ ALL, a type of leukemia where the abnormal BCR-ABL protein plays a key role in the proliferation of leukemic cells.
  • It may be used as part of combination chemotherapy.

• Dyronib is often prescribed to patients who have developed resistance to imatinib or who cannot tolerate its side effects.

• BCR-ABL Inhibition: Dasatinib inhibits the BCR-ABL tyrosine kinase (a fusion protein created by the Philadelphia chromosome), which is responsible for driving the uncontrolled growth of cancer cells in CML and ALL.
• Other Targeted Effects: It also inhibits other tyrosine kinases, including SRC family kinases, c-Kit, and epidermal growth factor receptor (EGFR), which contribute to cancer cell proliferation and survival.

150mg Axentri (Maraviroc) Tablets are used in the treatment of HIV-1 infection. Maraviroc is an antiretroviral medication that works by blocking a specific receptor on the surface of immune cells, which the HIV virus uses to enter and infect these cells.

1. HIV-1 Infection:

   • Axentri is used to treat HIV-1, the most common strain of the HIV virus. It is typically prescribed for treatment-experienced adults with HIV-1 infection who have evidence of CCR5-tropic HIV-1. This means the virus primarily uses the CCR5 receptor (a protein on the surface of immune cells) to enter and infect cells.

2. Combination Therapy:

   • Maraviroc is usually used in combination with other HIV medications, as part of a combination antiretroviral therapy (cART) regimen. It is not effective as a single drug for the treatment of HIV. The goal of combination therapy is to suppress the virus to undetectable levels in the blood, reduce the risk of drug resistance, and improve immune function.

3. Prevention of HIV Transmission:

   • By helping to suppress the virus and improve immune function, Axentri can also contribute to reducing the risk of HIV transmission to others, though it does not eliminate the need for safe practices such as condom use.

Afatinib (40 mg) is an oral medication classified as a tyrosine kinase inhibitor (TKI). It is primarily used in the treatment of certain types of cancer by targeting specific pathways involved in tumor growth. The medication is marketed under brand names like Giotrif or similar, depending on the region.

1. Non-Small Cell Lung Cancer (NSCLC):

   • Used for the treatment of advanced or metastatic NSCLC with specific genetic mutations, such as:
     • Epidermal Growth Factor Receptor (EGFR) mutations (e.g., exon 19 deletions or exon 21 L858R substitutions).
   • It is often prescribed as a first-line therapy for EGFR mutation-positive NSCLC.

2. Squamous Cell Carcinoma of the Lung:

   • Indicated for patients with advanced or metastatic squamous cell carcinoma of the lung who have progressed after treatment with platinum-based chemotherapy.

Afatinib irreversibly binds to and inhibits multiple members of the ErbB family of proteins (e.g., EGFR, HER2), which are involved in cell growth and survival. By blocking these pathways, Afatinib helps slow or stop cancer cell proliferation.

• Typically 40 mg once daily, taken on an empty stomach (at least 1 hour before or 2 hours after a meal).
• The dosage may be adjusted based on side effects or individual tolerability (reduced to 30 mg or 20 mg daily, if needed).

• Diarrhea (most common and may be severe)
• Skin rash or acne-like eruptions
• Mouth sores (stomatitis)
• Dry skin or itching
• Nausea and vomiting
• Decreased appetite

• Severe diarrhea leading to dehydration
• Lung-related complications (e.g., interstitial lung disease)
• Liver enzyme elevation
• Heart problems (e.g., heart failure, though rare)

• Regular monitoring of liver function and overall health is necessary during treatment.
• Not recommended for use during pregnancy or breastfeeding.
• Patients with a history of severe lung conditions should use Afatinib cautiously.

Afatinib is a targeted therapy and requires genetic testing (e.g., EGFR mutation testing) to confirm its suitability for a patient's specific cancer type. Always use it under the guidance of an oncologist.

Clenbut (Clenbuterol) 40 mg is a medication primarily used for its bronchodilator effects, though it is also sometimes used off-label for weight loss and bodybuilding purposes. Clenbuterol belongs to the beta-2 adrenergic agonists class of drugs, which stimulate certain receptors in the body to relax the muscles in the airways, allowing for easier breathing.

• Bronchodilation: Clenbuterol is used as a bronchodilator in the treatment of asthma and chronic respiratory conditions like COPD. It helps to relax the muscles around the airways, improving airflow and making it easier to breathe.
• Off-label Use for Bronchospasm: It may be prescribed off-label to treat bronchospasm (narrowing of the airways) caused by conditions like asthma.

• Fat Loss: Clenbuterol is sometimes used by bodybuilders, athletes, or those looking to lose weight as it has thermogenic properties that can increase metabolism and promote fat burning.
• Sympathomimetic Effect: It raises the body’s core temperature, which may increase calorie expenditure and fat loss over time.

• In some cases, Clenbuterol is used off-label to enhance performance due to its ability to improve oxygen delivery and endurance by opening up the airways and improving lung function.

• Anabolic Properties: It has mild anabolic (muscle-building) effects and is sometimes used in certain settings to help preserve lean muscle mass while promoting fat loss.

• Clenbuterol works by stimulating beta-2 receptors in the smooth muscles of the lungs, leading to bronchodilation (relaxing the muscles around the airways).
• Additionally, Clenbuterol has a thermogenic effect on the body, raising the basal metabolic rate, which can enhance fat burning.
• It also increases heart rate and blood pressure, leading to an increase in overall energy expenditure.

• Asthma/COPD Treatment: The typical dose for Clenbuterol when used for respiratory conditions is 20-40 mcg per day, which can be increased gradually based on tolerance. The usual adult dosage is 20-40 mcg once or twice daily.
• Fat Loss (Bodybuilding Use): Users may start with 20 mcg per day and gradually increase the dose, typically not exceeding 120-160 mcg per day in cycles. A common practice is to take Clenbuterol in cycles (e.g., 2 weeks on, 2 weeks off) to avoid desensitization and minimize side effects.

• Tremors or shaking (especially hands)
• Increased heart rate (tachycardia)
• Insomnia or difficulty sleeping
• Nausea and vomiting
• Headaches
• Dry mouth or throat irritation
• Sweating or feeling overheated
• Muscle cramps (due to electrolyte imbalance)

• Cardiac issues: Increased heart rate can be dangerous, especially for those with existing heart conditions. Clenbuterol can lead to arrhythmias (irregular heartbeats), palpitations, or even heart attacks in some cases.
• Hypertension (high blood pressure)
• Electrolyte imbalances, particularly low levels of potassium, which can lead to muscle cramps and weakness.
• Anxiety or nervousness at higher doses.

Saroglitazar (Bilypsa) 4 mg Tablets are used primarily in the treatment of non-alcoholic fatty liver disease (NAFLD) and type 2 diabetes. Saroglitazar is a dual peroxisome proliferator-activated receptor (PPAR) agonist, which means it acts on both PPAR-alpha and PPAR-gamma receptors. This action helps in improving insulin sensitivity and managing lipid levels, particularly triglycerides and cholesterol, which are often elevated in individuals with metabolic disorders such as diabetes or NAFLD.

1. Non-Alcoholic Fatty Liver Disease (NAFLD):

   • Treatment of NAFLD: Saroglitazar is approved for the treatment of NAFLD, a condition where fat accumulates in the liver without significant alcohol consumption. This can lead to liver inflammation, fibrosis, and cirrhosis if not managed.
   • Improvement in Liver Enzyme Levels: It helps reduce elevated liver enzymes (such as ALT and AST) that are typically seen in individuals with fatty liver disease.

2. Non-Alcoholic Steatohepatitis (NASH):

   • Treatment of NASH: Saroglitazar may also be beneficial for treating NASH, a more severe form of NAFLD, which involves liver inflammation and damage due to fat accumulation. It helps reduce liver fat content and improve liver function.

3. Type 2 Diabetes (Hyperglycemia Management):

   • Blood Sugar Control: Saroglitazar improves insulin sensitivity, which helps lower blood sugar levels in people with type 2 diabetes. It also helps reduce insulin resistance, a hallmark of type 2 diabetes, and assists in controlling both blood sugar and lipid profiles.
   • Triglyceride and Cholesterol Reduction: Saroglitazar is particularly effective in reducing elevated triglyceride and cholesterol levels in patients with diabetes or metabolic syndrome.

4. Dyslipidemia (Abnormal Lipid Levels):

   • Lipid Profile Improvement: Saroglitazar is used in individuals with abnormal lipid profiles (high triglycerides, high total cholesterol, or low HDL cholesterol), which are often seen in people with metabolic diseases such as diabetes or obesity.

Normoz Myo-Inositol Tablet is a dietary supplement commonly used for Polycystic Ovary Syndrome (PCOS) management, but it may also be used for other hormonal imbalances or fertility issues. Myo-inositol is a naturally occurring compound that belongs to the B-vitamin family, and it plays a role in various bodily functions, particularly in the regulation of hormones and insulin sensitivity.

1. Polycystic Ovary Syndrome (PCOS):

   • Improving Ovulation: Myo-inositol is often used to improve ovulatory function in women with PCOS, helping to regulate menstrual cycles and promote ovulation. This is particularly useful for women trying to conceive.
   • Insulin Sensitivity: Myo-inositol helps improve insulin sensitivity and can reduce insulin resistance, which is common in women with PCOS. By improving insulin function, it can help reduce high insulin levels, which are linked to ovarian dysfunction and anovulation (lack of ovulation).
   • Hormonal Balance: It helps regulate hormone levels, especially testosterone, which tends to be elevated in PCOS. By lowering high testosterone, Myo-inositol can help alleviate symptoms like acne, excess hair growth (hirsutism), and male-pattern hair loss.

2. Fertility Treatment:

   • Assisting Conception: In women with fertility issues due to PCOS or other causes, Myo-inositol can help improve the chances of successful pregnancy by supporting regular ovulation and improving egg quality.

3. Ovarian Health:

   • Restoring Ovarian Function: For women with ovarian dysfunction, Myo-inositol can help in restoring normal ovarian function and improving the health of the ovaries, potentially leading to better fertility outcomes.

4. Improving Metabolic Health:

   • Blood Sugar Regulation: Myo-inositol plays a role in glucose metabolism and helps maintain blood sugar levels, which is especially beneficial for women with PCOS who may have an increased risk of insulin resistance and type 2 diabetes.

5. Supporting Mental Health:

   • Myo-inositol has been shown to have a potential role in supporting mental health, particularly in improving symptoms of anxiety and depression, which are common in individuals with PCOS due to hormonal imbalances.

6. Improving Egg Quality:

   • For women undergoing in vitro fertilization (IVF) or other assisted reproductive treatments, Myo-inositol may help improve egg quality, enhancing the success rate of these treatments.

Estraheal (2 mg Estradiol) tablets are a form of estradiol, which is a synthetic version of the female hormone estrogen. Estradiol is used in hormone replacement therapy (HRT) to treat symptoms of menopause and other hormone-related conditions.

1. Menopausal Symptoms:

   • Hot Flashes: Estraheal is commonly used to alleviate hot flashes or night sweats that occur due to the decrease in estrogen levels during menopause.
   • Vaginal Dryness: It helps treat vaginal dryness, itching, or discomfort during intercourse caused by estrogen deficiency in postmenopausal women.
   • Mood Swings and Irritability: Estraheal may also help with mood changes, irritability, and anxiety commonly associated with menopause.
   • Sleep Disturbances: It can be used to reduce sleep problems such as insomnia that result from hormonal imbalances during menopause.

2. Hormone Replacement Therapy (HRT):

   • Estrogen Deficiency Treatment: Estraheal is used in hormone replacement therapy (HRT) to replace the estrogen that the body no longer produces after menopause. It is often prescribed as part of a combination therapy with a progestin (another hormone) to prevent the thickening of the uterine lining and reduce the risk of endometrial cancer.

3. Premature Menopause:

   • Premature Ovarian Insufficiency: Estraheal can be prescribed for women who experience premature menopause or early ovarian failure, helping restore hormonal balance and mitigate the symptoms associated with estrogen deficiency.

Tolvaheal is a brand name for Tolvaptan, a medication primarily used to treat certain types of kidney and heart conditions. It works as a vasopressin receptor antagonist, which affects water balance in the body. Below are the main uses and benefits of 15mg Tolvaheal (Tolvaptan) tablets:

• Tolvaptan is most commonly prescribed to slow the progression of autosomal dominant polycystic kidney disease (ADPKD). In ADPKD, cysts grow in the kidneys, impairing kidney function. Tolvaptan helps slow the growth of these cysts by blocking the action of vasopressin, a hormone that contributes to cyst growth and kidney damage.

• Tolvaptan is used to treat heart failure and hyponatremia (low blood sodium) caused by the condition. It works by reducing the excess water in the body, which helps improve symptoms like swelling (edema) and shortness of breath.

• Hyponatremia, often seen in patients with heart failure or liver cirrhosis, is a condition where the sodium level in the blood is too low. Tolvaptan helps increase sodium levels by promoting the excretion of excess water, thereby correcting hyponatremia and improving fluid balance.

• In some cases, Tolvaptan may be used for the treatment of chronic kidney disease where fluid retention or hyponatremia is a concern. It helps regulate water retention and balance in the body.

• Tolvaptan may also be used in the management of cirrhosis of the liver, particularly when ascites (fluid buildup in the abdomen) or hyponatremia is present. By blocking vasopressin, Tolvaptan helps improve water balance and reduce fluid retention.

• Tolvaptan works by blocking the V2 receptors for vasopressin in the kidneys. Vasopressin is responsible for regulating water reabsorption in the kidneys. By blocking its effect, Tolvaptan promotes the excretion of free water, which helps manage fluid balance and related conditions.

Rifagut is a brand name for Rifaximin, an antibiotic that is primarily used to treat gastrointestinal conditions caused by bacterial infections. Unlike many antibiotics that work throughout the body, Rifaximin mainly stays in the intestines, making it effective for treating intestinal infections without causing systemic side effects. Here are the main uses and benefits of 550mg Rifagut (Rifaximin) tablets:

• Rifaximin is commonly used to treat traveler’s diarrhea, typically caused by Escherichia coli (E. coli) bacteria. It helps reduce symptoms such as diarrhea, abdominal pain, and bloating by targeting the bacterial infection in the intestines.

• Rifaximin is approved for the treatment of IBS with diarrhea (IBS-D). It helps reduce symptoms like diarrhea, abdominal pain, and bloating, possibly by altering the gut microbiome and reducing bacterial overgrowth in the small intestine.

• Rifaximin is used as part of the treatment for hepatic encephalopathy, a condition caused by liver failure where toxins build up in the brain due to impaired liver function. Rifaximin helps reduce the levels of ammonia-producing bacteria in the intestines, which helps prevent the onset or recurrence of encephalopathy in patients with cirrhosis or liver disease.

• Rifaximin is often used to treat small intestinal bacterial overgrowth (SIBO), a condition where excessive bacteria grow in the small intestine. The antibiotic helps reduce the overgrowth of bacteria and alleviate symptoms such as bloating, diarrhea, and abdominal discomfort.

• In some cases, Rifaximin may be used off-label to prevent or treat Clostridium difficile infection (CDI), particularly in patients who are at high risk or have recurrent infections. It can help by eradicating the bacteria in the gut.

• Rifaximin works by inhibiting bacterial RNA synthesis. It binds to bacterial DNA-dependent RNA polymerase, preventing bacteria from producing proteins necessary for their survival. This leads to the death of the bacteria and helps clear the infection.

Iguvic 25mg is a brand name for Iguratimod, an immunomodulatory drug primarily used to treat certain autoimmune and inflammatory conditions. Here are the primary uses and benefits of Iguvic 25mg (Iguratimod) tablets:

• Iguratimod is most commonly used to treat rheumatoid arthritis (RA), a chronic autoimmune disorder that causes inflammation in the joints. RA leads to pain, swelling, stiffness, and potential joint damage. Iguvic helps by modulating the immune response to reduce inflammation, thereby relieving pain, improving joint function, and preventing further joint damage.

• Although less common than in RA, Iguratimod may sometimes be used to treat osteoarthritis (OA), especially in cases with significant inflammation. OA is a degenerative joint disease that causes pain and stiffness due to cartilage breakdown. Iguratimod can help reduce inflammation and improve mobility in affected joints.

• Iguratimod has been shown to help manage various autoimmune disorders by reducing the overactive immune response that causes damage to tissues and organs. It can be beneficial in conditions where inflammation is the result of immune system dysfunction.

• Iguratimod is thought to slow the progression of diseases like rheumatoid arthritis by reducing inflammation and preventing joint damage over time. It works by inhibiting certain inflammatory pathways and modulating immune system activity.

• Iguratimod works by modulating immune system activity, particularly through its effects on T-cells and cytokine production. It suppresses the overproduction of inflammatory substances like tumor necrosis factor-alpha (TNF-α) and interleukins, which are involved in the immune response and inflammation.